Treatment of primary aldosteronism

Best Practice and Research: Clinical Endocrinology and Metabolism

Volumn 24, Issue 6, 2010, Pages 923-932

  Quinkler, Marcus ^a   Stewart, Paul M ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Adrenalectomy; Con s adenoma; Eplerenone; Mineralocorticoid receptor; Primary aldosteronism; Spironolactone

Indexed keywords

ALDOSTERONE; AMILORIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; DEXAMETHASONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ELECTROLYTE; EPLERENONE; FLUDROCORTISONE; MINERALOCORTICOID ANTAGONIST; MITOTANE; NIFEDIPINE; PREDNISOLONE; PREDNISONE; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT; TRIAMTERENE;

ADENOMA; ADRENAL CORTEX CARCINOMA; ADRENAL HYPERPLASIA; ADRENALECTOMY; ALDOSTERONE BLOOD LEVEL; ALDOSTERONE PRODUCING ADENOMA; ANTIHYPERTENSIVE THERAPY; BEDTIME DOSAGE; BLOOD PRESSURE; BREAST TENDERNESS; CREATININE BLOOD LEVEL; DRUG DOSE TITRATION; DRUG HALF LIFE; ELECTROLYTE BLOOD LEVEL; ERECTILE DYSFUNCTION; GLOMERULUS FILTRATION RATE; GLUCOCORTICOID REMEDIABLE HYPERALDOSTERONISM; GYNECOMASTIA; HEALTH CARE COST; HEART FAILURE; HUMAN; HYPERTENSION; LIBIDO DISORDER; MENSTRUAL IRREGULARITY; NONHUMAN; PRIMARY HYPERALDOSTERONISM; RECOMMENDED DRUG DOSE; REVIEW; SODIUM RESTRICTION; UNSPECIFIED SIDE EFFECT;

ANIMALS; HUMANS; HYPERALDOSTERONISM; HYPERTENSION; PREVALENCE;

EID: 78649651749     PISSN: 1521690X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.beem.2010.10.001     Document Type: Review

References (97)

1. G.P. Rossi, G. Bernini, and C. Caliumi A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients Journal of American College of Cardiology 48 2006 2293 2300
2. B.L. Rayner, L.H. Opie, and J.S. Davidson The aldosterone/renin ratio as a screening test for primary aldosteronism South African Medical Journal 90 2000 394 400
3. C.E. Fardella, L. Mosso, and C. Gomez-Sanchez Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology Journal of Clinical Endocrinology and Metabolism 85 2000 1863 1867
4. K.C. Loh, E.S. Koay, and M.C. Khaw Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore Journal of Clinical Endocrinology and Metabolism 85 2000 2854 2859
5. R.D. Gordon, M. Stowasser, and T.J. Tunny High incidence of primary aldosteronism in 199 patients referred with hypertension Clinical and Experimental Pharmacology and Physiology 21 1994 315 318
6. P.O. Lim, E. Dow, and G. Brennan High prevalence of primary aldosteronism in the Tayside hypertension clinic population Journal of Human Hypertension 14 2000 311 315
7. B.J. Gallay, S. Ahmad, and L. Xu Screening for primary aldosteronism without discontinuing hypertensive medications: plasma aldosterone-renin ratio American Journal of Kidney Diseases 37 2001 699 705
8. P. Mulatero, M. Stowasser, and K.C. Loh Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents Journal of Clinical Endocrinology and Metabolism 89 2004 1045 1050
9. G.L. Schwartz, and S.T. Turner Screening for primary aldosteronism in essential hypertension: diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity Clinical Chemistry 51 2005 386 394
10. S. Douma, K. Petidis, and M. Doumas Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study Lancet 371 2008 1921 1926
11. N.M. Kaplan Is there an unrecognized epidemic of primary aldosteronism? Controversies in Hypertension 50 2007 454 458
12. L. Mosso, C. Carvajal, and A. Gonzalez Primary aldosteronism and hypertensive disease Hypertension 42 2003 161 165
13. D.A. Calhoun, M.K. Nishizaka, and M.A. Zaman Hyperaldosteronism among black and white subjects with resistant hypertension Hypertension 40 2002 892 896
14. I.K. Eide, P.A. Torjesen, and A. Drolsum Low-renin status in therapy-resistant hypertension: a clue to efficient treatment Journal of Hypertension 22 2004 2217 2226
15. B. Strauch, T. Zelinka, and M. Hampf Prevalence of primary hyperaldosteronism in moderate to severe hypertension in the Central Europe region Journal of Human Hypertension 17 2003 349 352
16. G.E. Umpierrez, P. Cantey, and D. Smiley Primary aldosteronism in diabetic subjects with resistant hypertension Diabetes Care 30 2007 1699 1703
17. P. Milliez, X. Girerd, and P.F. Plouin Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism Journal of the American College of Cardiology 45 2005 1243 1248
18. C. Catena, G. Colussi, and E. Nadalini Cardiovascular outcomes in patients with primary aldosteronism after treatment Archives of Internal Medicine 168 2008 80 85
19. E. Born-Frontsberg, M. Reincke, and L.C. Rump Cardio- and cerebrovascular comorbidites of hypo- and normokalemic primary aldosteronism: results of the German conn's registry Journal of Clinical Endocrinology and Metabolism 2009
20. M. Nishimura, T. Uzu, and T. Fujii Cardiovascular complications in patients with primary aldosteronism American Journal of Kidney Diseases 33 1999 261 266
21. M. Reincke, L.C. Rump, and M. Quinkler Risk factors associated with a low glomerular filtration rate in primary aldosteronism Journal of Clinical Endocrinology and Metabolism 94 2009 869 875
22. B. Strauch, O. Petrak, and D. Wichterle Increased arterial wall stiffness in primary aldosteronism in comparison with essential hypertension American Journal of Hypertension 19 2006 909 914
23. D. Rizzoni, S. Paiardi, and L. Rodella Changes in extracellular matrix in subcutaneous small resistance arteries of patients with primary aldosteronism Journal of Clinical Endocrinology and Metabolism 91 2006 2638 2642
24. D. Rizzoni, M.L. Muiesan, and E. Porteri Relations between cardiac and vascular structure in patients with primary and secondary hypertension Journal of the American College of Cardiology 32 1998 985 992
25. G. Bernini, F. Galetta, and F. Franzoni Arterial stiffness, intima-media thickness and carotid artery fibrosis in patients with primary aldosteronism Journal of Hypertension 26 2008 2399 2405
26. R. Holaj, T. Zelinka, and D. Wichterle Increased intima-media thickness of the common carotid artery in primary aldosteronism in comparison with essential hypertension Journal of Hypertension 25 2007 1451 1457
27. P. Mulatero, A. Verhovez, and F. Morello Diagnosis and treatment of low-renin hypertension Clinical Endocrinology 67 2007 324 334
28. M. Quinkler, and M. Reincke [Modern pharmacological aspects of hyperaldosteronism therapy.] Der Internist 2006
29. J.W. Funder, R.M. Carey, and C. Fardella Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline Journal of Clinical Endocrinology and Metabolism 2008
30. A.M. Sawka, W.F. Young, and G.B. Thompson Primary aldosteronism: factors associated with normalization of blood pressure after surgery Annals of Internal Medicine 135 2001 258 261
31. A. Meyer, G. Brabant, and M. Behrend Long-term follow-up after adrenalectomy for primary aldosteronism World Journal of Surgery 29 2005 155 159
32. O. Celen, M.J. O'Brien, J.C. Melby, and R.M. Beazley Factors influencing outcome of surgery for primary aldosteronism Archives of Surgery 131 1996 646 650
33. J.D. Blumenfeld, J.E. Sealey, and Y. Schlussel Diagnosis and treatment of primary hyperaldosteronism Annals of Internal Medicine 121 1994 877 885
34. D.A. Harris, I. Au-Yong, and P.S. Basnyat Review of surgical management of aldosterone secreting tumours of the adrenal cortex European Journal of Surgical Oncology 29 2003 467 474
35. M. Stowasser, S.A. Klemm, and T.J. Tunny Response to unilateral adrenalectomy for aldosterone-producing adenoma: effect of potassium levels and angiotensin responsiveness Clinical and Experimental Pharmacology and Physiology 21 1994 319 322
36. C.Y. Lo, P.C. Tam, and A.W. Kung Primary aldosteronism. Results of surgical treatment Annals of Surgery 224 1996 125 130
37. T.C. Pang, C. Bambach, and J.C. Monaghan Outcomes of laparoscopic adrenalectomy for hyperaldosteronism ANZ Journal of Surgery 77 2007 768 773
38. R.P. Ghose, P.M. Hall, and E.L. Bravo Medical management of aldosterone-producing adenomas Annals of Internal Medicine 131 1999 105 108
39. T. Nakada, Y. Kubota, and I. Sasagawa Therapeutic outcome of primary aldosteronism: adrenalectomy versus enucleation of aldosterone-producing adenoma Journal of Urology 153 1995 1775 1780
40. S. Ishidoya, A. Ito, and K. Sakai Laparoscopic partial versus total adrenalectomy for aldosterone producing adenoma Journal d'Urologie 174 2005 40 43
41. M. Omura, H. Sasano, and T. Fujiwara Unique cases of unilateral hyperaldosteronemia due to multiple adrenocortical micronodules, which can only be detected by selective adrenal venous sampling Metabolism 51 2002 350 355
42. J.M. Calvo-Romero, and J.L. Ramos-Salado Recurrence of adrenal aldosterone-producing adenoma Postgraduate Medical Journal 76 2000 160 161
43. G.P. Rossi, A.C. Pessina, and A.M. Heagerty Primary aldosteronism: an update on screening, diagnosis and treatment Journal of Hypertension 26 2008 613 621
44. W.F. Young Jr. Minireview: primary aldosteronism-changing concepts in diagnosis and treatment Endocrinology 144 2003 2208 2213
45. W.F. Young Jr., and G.G. Klee Primary aldosteronism. Diagnostic evaluation Endocrinology Metabolism Clinics of North America 17 1988 367 395
46. L. Baer, S.C. Sommers, and L.R. Krakoff Pseudo-primary aldosteronism. An entity distinct from true primary aldosteronism Circulation Research 27 1970 203 220
47. J.C. Gunnells Jr., N.M. Bath, and J. Sode Primary aldosteronism Archives of Internal Medicine 120 1967 568 574
48. J.T. Priestley, D.O. Ferris, and W.H. ReMine Primary aldosteronism: surgical management and pathologic findings Mayo Clinic Proceedings 43 1968 761 775
49. M.H. Weinberger, C.E. Grim, and J.W. Hollifield Primary aldosteronism: diagnosis, localization, and treatment Annals of Internal Medicine 90 1979 386 395
50. N. Sukor, R.D. Gordon, and Y.K. Ku Role of unilateral adrenalectomy in bilateral primary aldosteronism: a 22-year single center experience Journal of Clinical Endocrinology and Metabolism 94 2009 2437 2445
51. M. Stowasser Update in primary aldosteronism Journal of Clinical Endocrinology and Metabolism 94 2009 3623 3630
52. J.J. Brown, D.L. Davies, and J.B. Ferriss Comparison of surgery and prolonged spironolactone therapy in patients with hypertension, aldosterone excess, and low plasma renin British Medical Journal 2 1972 729 734
53. M.G. Crane, and J.J. Harris Effect of spironolactone in hypertensive patients American Journal of the Medical Sciences 260 1970 311 330
54. C.E. Kater, E.G. Biglieri, and M. Schambelan Studies of impaired aldosterone response to spironolactone-induced renin and potassium elevations in adenomatous but not hyperplastic primary aldosteronism Hypertension 5 1983 V115 V121
55. D. Kremer, D.G. Beevers, and J.J. Brown Spironolactone and amiloride in the treatment of low renin hyperaldosteronism and related syndromes Clinical Science and Molecular Medicine Supplement 1 Suppl. 45 1973 213s 218s
56. P.O. Lim, R.T. Jung, and T.M. MacDonald Raised aldosterone to renin ratio predicts antihypertensive efficacy of spironolactone: a prospective cohort follow-up study British Journal of Clinical Pharmacology 48 1999 756 760
57. A. Helber, G. Wambach, and W. Hummerich Evidence for a subgroup of essential hypertensives with non-suppressible excretion of aldosterone during sodium loading Klinische Wochenschrift 58 1980 439 447
58. G. Wambach, A. Helber, and G. Bonner [Spironolactone in essential hypertension associated with abnormal aldosterone regulation and in conn's syndrome (author's transl)] Deutsche Medizinische Wochenschrift 105 1980 647 651
59. X. Jeunemaitre, G. Chatellier, and C. Kreft-Jais Efficacy and tolerance of spironolactone in essential hypertension American Journal of Cardiology 60 1987 820 825
60. M.H. Weinberger, B. Roniker, and S.L. Krause Eplerenone, a selective aldosterone blocker, in mild-to-moderate hypertension American Journal of Hypertension 15 2002 709 716
61. E.D. Burgess, Y. Lacourciere, and L.M. Ruilope-Urioste Long-term safety and efficacy of the selective aldosterone blocker eplerenone in patients with essential hypertension Clinical Therapeutics 25 2003 2388 2404
62. B. Pitt, W. Remme, and F. Zannad Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction New England Journal of Medicine 348 2003 1309 1321
63. A. Karagiannis, K. Tziomalos, and A. Papageorgiou Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism Expert Opinion on Pharmacotherapy. 9 2008 509 515
64. P.O. Lim, W.F. Young, and T.M. MacDonald A review of the medical treatment of primary aldosteronism Journal of Hypertension 19 2001 353 361
65. C.A. Farquharson, and A.D. Struthers Increasing plasma potassium with amiloride shortens the QT interval and reduces ventricular extra systoles but does not change endothelial function or heart rate variability in chronic heart failure Heart 88 2002 475 480
66. K.T. Weber, and C.G. Brilla Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system Circulation 83 1991 1849 1865
67. J.D. Spence Diagnosis of primary aldosteronism: for medical management, not just surgery Journal of Hypertension 27 2009 204 205
68. M. Wisgerhof, P.C. Carpenter, and R.D. Brown Increased adrenal sensitivity to angiotensin II in idiopathic hyperaldosteronism Journal of Clinical Endocrinology and Metabolism 47 1978 938 943 (Pubitemid 9047376)
69. G.T. Griffing, and J.C. Melby The therapeutic use of a new potassium-sparing diuretic, amiloride, and a converting enzyme inhibitor, MK-421, in preventing hypokalemia associated with primary and secondary hyperaldosteronism Clinical and Experimental Hypertension 5 1983 779 801
70. F. Mantero, F. Fallo, and G. Opocher Effect of angiotensin II and converting enzyme inhibitor (captopril) on blood pressure, plasma renin activity and aldosterone in primary aldosteronism Clinical Science (London) 7 Suppl. 61 1981 289s 293s
71. J.L. Nadler, W. Hsueh, and R. Horton Therapeutic effect of calcium channel blockade in primary aldosteronism Journal of Clinical Endocrinology and Metabolism 60 1985 896 899
72. M. Stimpel, K. Ivens, and G. Wambach Are calcium antagonists helpful in the management of primary aldosteronism? Journal of Cardiovascular Pharmacology 6 Suppl. 12 1988 S131 S134
73. G. Carpene, S. Rocco, and G. Opocher Acute and chronic effect of nifedipine in primary aldosteronism Clinical and Experimental Hypertension 11 1989 1263 1272
74. G. Opocher, S. Rocco, and A. Murgia Effect of verapamil on aldosterone secretion in primary aldosteronism Journal of Endocrinological Investigation 10 1987 491 494
75. M. Bursztyn, E. Grossman, and T. Rosenthal The absence of long-term therapeutic effect of calcium channel blockade in the primary aldosteronism of adrenal adenomas American Journal of Hypertension 1 1988 88S 90S
76. M. Stimpel, K. Ivens, and H.P. Volkmann Therapeutic value of calcium antagonists in autonomous hyperaldosteronism Klinische Wochenschrift 67 1989 248 252
77. J.D. Dietz, S. Du, and C.W. Bolten A number of marketed dihydropyridine calcium channel blockers have mineralocorticoid receptor antagonist activity Hypertension 51 2008 742 748
78. T.M. Seccia, A. Fassina, and G.G. Nussdorfer Aldosterone-producing adrenocortical carcinoma: an unusual cause of conn's syndrome with an ominous clinical course Endocrine Related Cancer 12 2005 149 159
79. S.R. Bornstein, C.A. Stratakis, and G.P. Chrousos Adrenocortical tumors: recent advances in basic concepts and clinical management Annals of Internal Medicine 130 1999 759 771
80. B. Allolio, and M. Fassnacht Clinical review: adrenocortical carcinoma: clinical update Journal of Clinical Endocrinology and Metabolism 91 2006 2027 2037
81. J. Wortsman, and N.G. Soler Mitotane. Spironolactone antagonism in cushing's syndrome Journal of American Medical Association 238 1977 2527
82. R.P. Lifton, R.G. Dluhy, and M. Powers A chimaeric 11 beta-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension Nature 355 1992 262 265
83. L. Pascoe, K.M. Curnow, and L. Slutsker Glucocorticoid-suppressible hyperaldosteronism results from hybrid genes created by unequal crossovers between CYP11B1 and CYP11B2 Proceedings of National Academy of Sciences of the United States of America 89 1992 8327 8331
84. M. Stowasser, and R.D. Gordon Familial hyperaldosteronism Journal of Steroid Biochemistry and Molecular Biology 78 2001 215 229
85. R.G. Dluhy, B. Anderson, and B. Harlin Glucocorticoid-remediable aldosteronism is associated with severe hypertension in early childhood Jornal de Pediatria 138 2001 715 720
86. P.M. Jansen, A.H. van den Meiracker, and A.H. Jan Danser Aldosterone synthase inhibitors: pharmacological and clinical aspects Current Opinion in Investigational Drugs 10 2009 319 326
87. A.M. Marney, and N.J. Brown Aldosterone and end-organ damage Clinical Science (London) 113 2007 267 278
88. G.P. Rossi, L.A. Sechi, and G. Giacchetti Primary aldosteronism: cardiovascular, renal and metabolic implications Trends in Endocrinology and Metabolism 19 2008 88 90
89. R. Rocha, and C.T. Stier Jr. Pathophysiological effects of aldosterone in cardiovascular tissues Trends in Endocrinology and Metabolism 12 2001 308 314
90. B. Pitt, F. Zannad, and W.J. Remme The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized aldactone evaluation study investigators New England Journal of Medicine 341 1999 709 717
91. B. Pitt, N. Reichek, and R. Willenbrock Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study Circulation 108 2003 1831 1838
92. C. Catena, G. Colussi, and R. Lapenna Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism Hypertension 50 2007 911 918
93. G. Giacchetti, V. Ronconi, and F. Turchi Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study Journal of Hypertension 25 2007 177 186
94. G.P. Rossi, A. Sacchetto, and E. Pavan Remodeling of the left ventricle in primary aldosteronism due to conn's adenoma Circulation 95 1997 1471 1478
95. L.A. Sechi, M. Novello, and R. Lapenna Long-term renal outcomes in patients with primary aldosteronism Journal of American Medical Association 295 2006 2638 2645
96. N. Sukor, C. Kogovsek, R.D. Gordon, D. Robson, and M. Stowasser Improved quality of life, blood pressure, and biochemical status following laparoscopic adrenalectomy for unilateral primary aldosteronism Journal Clinical Endocrinology and Metabolism 95 3 2010 1360 1364
97. L. Amar, M. Azizi, J. Menard, S. Peyrard, C. Watson, and P.F. Plouin Aldosterone Synthase Inhibition With LCI699. A Proof-of-Concept Study in Patients With Primary Aldosteronism Hypertension 2010 Sep 13 [Epub ahead of print]